Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upFlorian Lordick, Dirk Arnold, C. Mariette et al.|Annals of Oncology|2016Cited by 1.1k
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 studyJosep Tabernero, Federico Nasroulah, Tudor–Eliade Ciuleanu et al.|The Lancet Oncology|2015Cited by 954
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upRadka Obermannová, Elizabeth Smyth, Arndt Vogel et al.|Annals of Oncology|2022Cited by 646
Preoperative Chemoradiotherapy for Gastroesophageal Junction Adenocarcinoma Modified by PET/CT: Results of Virtual Planning StudyM Slavík, Radka Obermannová|Medicina|2021Cited by 0